IPI-493

CAS No. 64202-81-9

IPI-493( —— )

Catalog No. M34626 CAS No. 64202-81-9

IPI-493 (17-amino17demethoxy) is a novel HSP90 inhibitor with antitumor activity.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 445 Get Quote
5MG 686 Get Quote
10MG 938 Get Quote
25MG 1398 Get Quote
50MG 1822 Get Quote
100MG 2484 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    IPI-493
  • Note
    Research use only, not for human use.
  • Brief Description
    IPI-493 (17-amino17demethoxy) is a novel HSP90 inhibitor with antitumor activity.
  • Description
    IPI-493 (17-amino17demethoxy) is a novel HSP90 inhibitor with antitumor activity.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Cytoskeleton/Cell Adhesion Molecules
  • Target
    HSP
  • Recptor
    HSP
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    64202-81-9
  • Formula Weight
    545.62
  • Molecular Formula
    C28H39N3O8
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O=C(NC(C1=O)=CC2=O)/C(C)=C/C=C/[C@@H]([C@H](/C(C)=C/[C@@H]([C@H]([C@H](C[C@@H](CC1=C2N)C)OC)O)C)OC(N)=O)OC
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • PF-04929113 Mesylate

    The prodrug of PF-04928473 (SNX-2112), a potent, orally bioavailable HSP90 inhibitor.

  • Retaspimycin hydroch...

    A water-soluble derivative of 17-AAG and HSP90 inhibitor.

  • NSC 145366

    NSC 145366 is a novel, allosteric Hsp90 CTD (C-terminal domain) inhibitor.